Collplant Biotechnologies Ltd (CLGN) is a Healthcare · Biotechnology company listed on NASDAQ. Price $4.56 (+9.62%), Market cap $0.01B, 52-week low–high $0.29 ~ $4.54.
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. The company offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; Collage, a combinant human Collagen type I solution; VergenixSTR, a soft tissue matrix for the treatment of tendinopathy; and VergenixFG, a wound care product for the treatment of deep surgical incisions and deep wounds. It also prov
Financial statements, price targets, institutional (13F) holdings and related news for Collplant Biotechnologies Ltd are updated in real time on BlackAll Trade.
Collplant Biotechnologies Ltd trades at $4.56 (+9.62%). Real-time quotes and charts are available on BlackAll Trade.
Collplant Biotechnologies Ltd has a market cap of about $0.01B.
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada,